- The Myeloma Beacon - https://myelomabeacon.org -

Aplidin (plitidepsin)

By: Admin; Published: October 15, 2008 @ 8:00 am | Comments Disabled

Brand Name: Aplidin
Generic Name: plitidepsin
Code Name:
Company: PharmaMar, SA
FDA Clinical Phase: 3

Description:

Aplidin is derived from a compound found in tunicates which shows promise in shrinking tumors. The specific marine organism is Aplidium albicans.

Clinical Trials:
For a list of clinical trials studying Aplidin for the treatment of multiple myeloma, see ClinicalTrials.gov [1].

Information about Aplidin also is available at the PharmaMar [2] website.

Source: Wikipedia [3] article about Aplidin (as of November 14, 2009).

Article printed from The Myeloma Beacon: https://myelomabeacon.org

URL to article: https://myelomabeacon.org/resources/2008/10/15/aplidin/

URLs in this post:

[1] ClinicalTrials.gov: http://www.clinicaltrial.gov/ct2/results?term=aplidin&recr=&rslt=&type=&cond=multiple+myeloma&intr=&outc=&lead=&spons=&id=&state1=&cntry1=&state2=&cntry2=&state3=&cntry3=&locn=&gndr=&rcv_s=&rcv_e=&lup_s=&lup_e=

[2] PharmaMar: http://www.pharmamar.com/aplidin.aspx

[3] Wikipedia: http://en.wikipedia.org/wiki/Aplidine

Copyright © The Beacon Foundation for Health. All rights reserved.